Cargando…
Clinical validation of the Tempus xO assay
We have developed a clinically validated NGS assay that includes tumor, germline and RNA sequencing. We apply this assay to clinical specimens and cell lines, and we demonstrate a clinical sensitivity of 98.4% and positive predictive value of 100% for the clinically actionable variants measured by t...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995233/ https://www.ncbi.nlm.nih.gov/pubmed/29899824 http://dx.doi.org/10.18632/oncotarget.25381 |
_version_ | 1783330577099784192 |
---|---|
author | Beaubier, Nike Tell, Robert Huether, Robert Bontrager, Martin Bush, Stephen Parsons, Jerod Shah, Kaanan Baker, Tim Selkov, Gene Taxter, Tim Thomas, Amber Bettis, Sam Khan, Aly Lau, Denise Lee, Christina Barber, Matthew Cieslik, Marcin Frankenberger, Casey Franzen, Amy Weiner, Ali Palmer, Gary Lonigro, Robert Robinson, Dan Wu, Yi-Mi Cao, Xuhong Lefkofsky, Eric Chinnaiyan, Arul White, Kevin P. |
author_facet | Beaubier, Nike Tell, Robert Huether, Robert Bontrager, Martin Bush, Stephen Parsons, Jerod Shah, Kaanan Baker, Tim Selkov, Gene Taxter, Tim Thomas, Amber Bettis, Sam Khan, Aly Lau, Denise Lee, Christina Barber, Matthew Cieslik, Marcin Frankenberger, Casey Franzen, Amy Weiner, Ali Palmer, Gary Lonigro, Robert Robinson, Dan Wu, Yi-Mi Cao, Xuhong Lefkofsky, Eric Chinnaiyan, Arul White, Kevin P. |
author_sort | Beaubier, Nike |
collection | PubMed |
description | We have developed a clinically validated NGS assay that includes tumor, germline and RNA sequencing. We apply this assay to clinical specimens and cell lines, and we demonstrate a clinical sensitivity of 98.4% and positive predictive value of 100% for the clinically actionable variants measured by the assay. We also demonstrate highly accurate copy number measurements and gene rearrangement identification. |
format | Online Article Text |
id | pubmed-5995233 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-59952332018-06-13 Clinical validation of the Tempus xO assay Beaubier, Nike Tell, Robert Huether, Robert Bontrager, Martin Bush, Stephen Parsons, Jerod Shah, Kaanan Baker, Tim Selkov, Gene Taxter, Tim Thomas, Amber Bettis, Sam Khan, Aly Lau, Denise Lee, Christina Barber, Matthew Cieslik, Marcin Frankenberger, Casey Franzen, Amy Weiner, Ali Palmer, Gary Lonigro, Robert Robinson, Dan Wu, Yi-Mi Cao, Xuhong Lefkofsky, Eric Chinnaiyan, Arul White, Kevin P. Oncotarget Research Paper We have developed a clinically validated NGS assay that includes tumor, germline and RNA sequencing. We apply this assay to clinical specimens and cell lines, and we demonstrate a clinical sensitivity of 98.4% and positive predictive value of 100% for the clinically actionable variants measured by the assay. We also demonstrate highly accurate copy number measurements and gene rearrangement identification. Impact Journals LLC 2018-05-25 /pmc/articles/PMC5995233/ /pubmed/29899824 http://dx.doi.org/10.18632/oncotarget.25381 Text en Copyright: © 2018 Beaubier et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Research Paper Beaubier, Nike Tell, Robert Huether, Robert Bontrager, Martin Bush, Stephen Parsons, Jerod Shah, Kaanan Baker, Tim Selkov, Gene Taxter, Tim Thomas, Amber Bettis, Sam Khan, Aly Lau, Denise Lee, Christina Barber, Matthew Cieslik, Marcin Frankenberger, Casey Franzen, Amy Weiner, Ali Palmer, Gary Lonigro, Robert Robinson, Dan Wu, Yi-Mi Cao, Xuhong Lefkofsky, Eric Chinnaiyan, Arul White, Kevin P. Clinical validation of the Tempus xO assay |
title | Clinical validation of the Tempus xO assay |
title_full | Clinical validation of the Tempus xO assay |
title_fullStr | Clinical validation of the Tempus xO assay |
title_full_unstemmed | Clinical validation of the Tempus xO assay |
title_short | Clinical validation of the Tempus xO assay |
title_sort | clinical validation of the tempus xo assay |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995233/ https://www.ncbi.nlm.nih.gov/pubmed/29899824 http://dx.doi.org/10.18632/oncotarget.25381 |
work_keys_str_mv | AT beaubiernike clinicalvalidationofthetempusxoassay AT tellrobert clinicalvalidationofthetempusxoassay AT huetherrobert clinicalvalidationofthetempusxoassay AT bontragermartin clinicalvalidationofthetempusxoassay AT bushstephen clinicalvalidationofthetempusxoassay AT parsonsjerod clinicalvalidationofthetempusxoassay AT shahkaanan clinicalvalidationofthetempusxoassay AT bakertim clinicalvalidationofthetempusxoassay AT selkovgene clinicalvalidationofthetempusxoassay AT taxtertim clinicalvalidationofthetempusxoassay AT thomasamber clinicalvalidationofthetempusxoassay AT bettissam clinicalvalidationofthetempusxoassay AT khanaly clinicalvalidationofthetempusxoassay AT laudenise clinicalvalidationofthetempusxoassay AT leechristina clinicalvalidationofthetempusxoassay AT barbermatthew clinicalvalidationofthetempusxoassay AT cieslikmarcin clinicalvalidationofthetempusxoassay AT frankenbergercasey clinicalvalidationofthetempusxoassay AT franzenamy clinicalvalidationofthetempusxoassay AT weinerali clinicalvalidationofthetempusxoassay AT palmergary clinicalvalidationofthetempusxoassay AT lonigrorobert clinicalvalidationofthetempusxoassay AT robinsondan clinicalvalidationofthetempusxoassay AT wuyimi clinicalvalidationofthetempusxoassay AT caoxuhong clinicalvalidationofthetempusxoassay AT lefkofskyeric clinicalvalidationofthetempusxoassay AT chinnaiyanarul clinicalvalidationofthetempusxoassay AT whitekevinp clinicalvalidationofthetempusxoassay |